Abstract:The incidence of hepatocellular carcinoma(HCC) has increased worldwide over the past two decades.Surgical resection and liver transplantation have been demonstrated as potentially curative treatment options,which could be considered in 30% to 40% of HCC patients.Recent advancements of surgical treatment have focused not only on the surgical techniques,but also the hepatic functional reserve evaluation,resectability assessment and the effects of biological characteristics of tumor on prognosis.There is no single variable to evaluate hepatic functional reserve accurately.The combination of Child-Pugh classification,15-minute retention rate?for?Indocyanine Green(ICG15),portal vein pressure and remanent liver volume measurement is a reasonable strategy prior to Child-Pugh classification alone for liver resection.Five-year survival rate after liver resection for HCC is about 50%.The results may be acceptable for some selected patients underwent tumor resection with thrombectomy,including HCC with portal vein tumor thrombus and bile duct thrombosis.The choice of local resection or regular hepatectomy is still controversial although the former is common in HCC with cirrhosis,and the latter is in the setting without liver cirrhosis.The result of liver transplantation for HCC is better than that of liver resection,and Milan criteria is a generally accepted algorithm.Any attempts to expand the selection criteria should be cautious in the present setting of organ shortage.Salvage transplantation for intra-hepatic recurrence after liver resection may be a good choice in some resectable HCC.The recurrence and metastasis after surgical treatments are of the main obstacle to achieve better results.Identification of predictive factors could be helpful to develop prevention strategies.Due to the importance of biological characteristics in tumor recurrence and metastasis,a molecular classification to predict prognosis of HCC will lead to a more personalized medicine.Targeting key molecules of biological pathways could optimize therapeutic modality in HCC.

Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

[Ten-Year Retrospect of ALPPS in the Treatment of Hepatocellular Carcinoma:An Eternal Concept with Cautious Technologic Choice].

Recent Advances in Liver Transplantation for Hepatocellular Carcinoma

Liver Transplantation in China: Problems and Their Solutions.

Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future

Experience of living donor liver transplantation for hepatocellular carcinoma in the University of Hong Kong Hospital

Progress in Surgical Procedures of Hepatocellular Carcinoma

Liver Transplantation meets Cancer

Value of Liver Transplantation in Hepatocellular Carcinoma Treatment

Advancements in the Surgical Treatment of Hepatocellular Carcinoma

[Selection Criteria for Liver Transplantation Recipients of Hepatocellular Carcinoma].

An Overview of Liver Transplantation: Current Status, Recent Techniques, and Challenges-Perspectives From a Center in China.

The Trend of Liver Transplantation for Primary Hepatocellular Carcinoma

Systemic Therapy Alters the Landscape of Surgery in Hepatocellular Carcinoma： Opportunities and Challenges

The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021

New Scenarios in Liver Transplantation for Hepatocellular Carcinoma

Review and Prospect of Clinical Study on Liver Transplantation of Hepatocellular Carcinoma

The current landscape of therapies for hepatocellular carcinoma

Current approaches to the treatment of early hepatocellular carcinoma.

Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis